Company intelligence / Profile preview

LifeVac

Nesconset, New York, United Stateslifevac.net ↗

Ownership: Private
Development stage: Commercial

Overview

LifeVac is a commercially available, FDA Class II registered, non-powered, non-invasive airway clearance device designed to resuscitate individuals experiencing choking when standard protocols fail or are not feasible. The device has been credited with saving nearly 4,000 lives globally as of 2024. While supported by case reports and some peer-reviewed studies, large-scale clinical trial data remain limited[2][3][5][6].

Therapeutic areas: Pulmonology
Modalities: DeviceNon-pharmacological therapy (airway clearance)
Industry: Therapeutic Medical Devices

Partnerships

Used by first responders including fire and police departments[2]Deployed in schools and care facilities[2]

Beyond the preview

Go deeper on LifeVac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeVac.

Explore the full profile